On May 30, 2018, Soleno Therapeutics, Inc. announced that Jonathan Wolter transitioned to the company's Chief Financial Officer on a non-interim basis. Mr. Wolter has been serving as the Company's interim Chief Financial Officer since September 5, 2017. In connection with the transition, Mr. Wolter will also serve as the Company's principal financial and accounting officer.